Bell Investment Advisors, Inc Cytokinetics Inc Transaction History
Bell Investment Advisors, Inc
- $538 Million
- Q1 2025
A detailed history of Bell Investment Advisors, Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 57 shares of CYTK stock, worth $1,778. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57
Previous 32
78.13%
Holding current value
$1,778
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $2.94B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...